Is Homology Medicines, Inc. a good investment? Homology Medicines, Inc. (FIXX) is currently trading at 13.04 USD.
Earnings Schedule: Homology Medicines, Inc. is expected to release its next earnings report on May 5, 2026.
No, it does not currently pay a dividend.
Homology Medicines, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be May 5, 2026.
The fund invests at least 80% of its net assets (plus borrowings for investment purposes) in the underlying security and financial instruments with economic characteristics that, in combination, provide 200% leveraged exposure to the price of the underlying security, on a daily basis, consistent with the fund’s investment objective. It is non-diversified.
Community Discussion